No products in the cart.
Merck beats quarterly estimates on strength of Keytruda and new products, narrows outlook
2026-04-30
In this article MRK Follow your favorite stocksCREATE FREE ACCOUNT Dado Ruvic | Reuters Merck on Thursday reported first-quarter results that topped estimates on strongContinue Reading








